Separation of clinical quantities of CD34+ cells from human marrow using immunomagnetic procedures.
Burgess
J
J
Immunotherapy Division, Baxter Healthcare Corporation, Santa Ana, California.
Traycoff
C
C
Hardwick
A
A
Smith
A
A
Hangoc
G
G
Ishizawa
L
L
Moubayed
M
M
Broun
R
R
Srour
E
E
Gee
A
A
D015703:Antigens, CD / Q000378:metabolism*; D018952:Antigens, CD34; D001853:Bone Marrow / Q000187:drug effects / Q000276:immunology*; D001854:Bone Marrow Cells; D003114:Colony-Forming Units Assay; D017077:Culture Media, Conditioned; D004921:Erythropoietin / Q000494:pharmacology; D005069:Evaluation Studies as Topic; D005434:Flow Cytometry; D005455:Fluorescent Antibody Technique; D006801:Humans; D018189:Immunomagnetic Separation / Q000295:instrumentation / Q000379:methods*; D066298:In Vitro Techniques
D015703:Antigens, CD; D018952:Antigens, CD34; D017077:Culture Media, Conditioned; D004921:Erythropoietin